PainTEQ Fuels Next Phase of Growth at NANS 2026 with Strategic Expansion of Innovation, Clinical Initiatives, and Product Portfolio
PR Newswire —
TAMPA, Fla., Jan. 20, 2026 /PRNewswire/ -- PainTEQ, a leader in minimally invasive solutions for sacroiliac (SI) joint dysfunction, today announced a significant investment in its clinical and commercial operations ahead of the North American Neuromodulation Society (NANS) 2026 Annual...